Completed
A Phase 2 Study of Linsitinib (OSI-906) in Pediatric and Adult Wild Type Gastrointestinal Stromal Tumors
Type of Sarcoma:
Gastrointestinal stromal tumors
Drug:
OSI-906
Accrual Status:
Completed
Overall Study Principal Investigator:
Margaret von Mehren, MD
Fox Chase Cancer Center